Mesenchymal Stem Cell Therapy for Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disease responsible for 60-70% of the 50 million cases of dementia worldwide. It is characterized by neuronal cell death, shrinkage of brain tissue, and progressive cognitive, motor, and behavioral impairment, which often leads to death. Although curre...
Saved in:
| Main Authors: | A. E. Hernández, E. García |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2021/7834421 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal stem cell application in Alzheimer's disease
by: Qianying Feng, et al.
Published: (2025-12-01) -
Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases
by: Katherine Athayde Teixeira de Carvalho, et al.
Published: (2015-01-01) -
Mesenchymal stem cells (MSCs) in cell therapy
by: E. B. Vladimirskaya
Published: (2022-11-01) -
Exploration of Cytokines That Impact the Therapeutic Efficacy of Mesenchymal Stem Cells in Alzheimer’s Disease
by: Herui Wang, et al.
Published: (2025-06-01) -
Therapeutic Applications of Dental Mesenchymal Stem Cells in Alzheimer’s Disease—A Scoping Review
by: Rupali Agnihotri, et al.
Published: (2025-06-01)